Fierce Pharma

Updates on DTC advertising and DTP programs, as well as [...]

After a series of ownership changes, Andexxa is slated to [...]

The Elevidys-related manufacturing shortfalls were described in one of two [...]

Sixteen months after luring former Roche dealmaker James Sabry, M.D., [...]

Amgen, Boehringer Ingelheim, Bristol Myers Squibb, Gilead Sciences, GSK, Merck [...]

As the FDA steadily churns out a stream of untitled [...]

Amid rapidly evolving media consumption habits and a federal push [...]

As Eli Lilly gears up to support its partnered athletes, [...]

Within the mammoth defense bill, the Biosecure Act has the [...]

“Following the withdrawal of Ocaliva from the U.S. market, we [...]